U.S. stock market anomaly | Weight loss drug concept stocks are generally up, Eli Lilly (LLY.US) up more than 4%.

On Tuesday, stocks related to weight loss drugs initially rose broadly, with eli lilly and co (LLY.US) up over 4%, scpharmaceuticals (GPCR.US) up over 2%, and novo-nordisk a/s (NVO.US) up over 2%.

Zhitong FinanceNov 26 09:50 ET

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs

WSJNov 26 05:37 ET

We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate

Simply Wall StNov 25 07:27 ET

Trump Nominates Marty Makary For FDA Commissioner

Barron'sNov 22 22:27 ET

The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 07:00 ET

Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post

MarketWatchNov 15 14:25 ET